Home > Drug Search >
  • company_query: Brainstorm Cell Therapeutics
  •   > 
Drug Filter
Category:
chemistry (8) biology (26)
Status:
Approved (1) Phase Ⅲ (4) Phase Ⅱ (18) Phase Ⅰ (11)
Clinical Stage:
Pending (4) Active (25) Discontinued (4)
Bio-Type:
Gene therapy (5) Cell therapy (2) Vaccine (14) Recombinant enzyme (1) Recombinant polypeptide (1) Other recombinant protein (1) Whole antibody (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (2) Basal cell carcinoma (BCC) (1) Breast cancer (2) ischaemic heart disorder (1) Community-acquired pneumonia (CAP) (2) Cystic fibrosis (CF) (1) Bronchitis (1) Diabetic nephropathy (1) Endometrial cancer (1) Heart failure (1) Rabies (2) Lung cancer (1) Melanoma (3) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Peripheral arterial disease (PAD) (1) Measles (1) Prostate cancer (2) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Smoking cessation (1) Solid tumours (5) Thrombocytopenia (1) Leber congenital amaurosis (1) Tuberculosis (1) Head and neck cancer (1) Colorectal cancer (2) Fallopian tube cancer (1) Nosocomial Pneumonia (NP) (1) Bacterial Pneumonia (1) Systemic inflammatory response syndrome (SIRS) (1) Sarcoma (1) Peritoneum cancer (1) Glioblastoma (1) Glioma (1) Graft versus host disease (1) Mesothelioma (2) Liver cancer (1) Renal failure (1) hematological malignancies (1) Cervical dysplasia (1) Myocardia ischemia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top